Icon
+91 94997 68112
Login Register

Zioptan - (0.0015%; Solution/Drops, Ophthalmic)

Tafluprost OAK Pharmaceuticals
0.0015%; Solution/Drops, Ophthalmic
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
Less Than 5
Less Than 5
Indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Yes
***** **** *** ****** *** *** ***** ** **** **** ** **** ****** '*** (*** **, ****) *** **** ************ *********. ** ****** **** **** *** **** ****** ** **** ****. ****** *** ****** ** ** ****** **** ********** *** ********* **** ****** ***** *** ***** ** ********* *** *** ***** . * *** ****** '*** (*** **, ****) *** ****** ** *** ********* *** ********* ***** ******* **** ******* ***** **** **** *** ***** ****** *******.
Zioptan Patent 1 Patent 2 Patent 3
********* ******* ******* *******
****** ******* ******* *******
******* ****** *** ********* *** ********* *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
********* *** \ ** *** **, **** ******* ******** ******** ** *** ****
****** *** \ ** *** **, **** ******* ******** ******** ** *** ****
******* ****** ** \ ** -**- *** ********* ******** *** ****** *******
  1. *** *, **** : ***** **** *** ****** ********** ******* ****** *** *** ****** ***** *** **** ** **** ****** '*** (*** **, ****).
  2. *** **, **** : ****** *** *** ****** ***** ******** ***** ******* ***** **** *** ****** ** ******* ***** ** ********.
  3. *** *, **** : ********** *** ********* **** ****** ***** *** ***** ** ********* *** *** *****.
  4. *** **, **** : * *** ****** '*** (*** **, ****) *** ****** ** ****** & *** ******.
  5. *** *, **** : ****** & *** ****** ***** * **** ******* ********* **** *** ***** ****** ****** '*** (*** **, ****).
  6. *** **, **** : ********** ********* **** ***** **** *** ****** '*** (*** **, ****).
  7. *** *, **** : ******* ****** *** ********. **, ** ****** **** ***** **** ***** **** ** *** ** ** *** *********.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.